Results 41 to 50 of about 99,201 (311)
Haematologica, 2018 Aprior phase I/II trial of bortezomib/tacrolimus/methotrexate prophylaxis after human leukocyte antigen (HLA)-mismatched reduced intensity conditioning allogeneic hematopoietic stem cell transplantation documented low acute graft-versus-host disease ...
John Koreth +19 more
doaj +1 more source
Febrile Neutropenia in Hematologic Malignancies
, 2013 Febrile neutropenia (FN) can occur at any time during the course of a malignancy, especially hematologic malignancies, from diagnosis to end-stage disease.
Sekeres, Mikkael A., Keng, Michael K.
core +1 more source
New developments in immunotherapy for lymphoma
Cancer Biology & Medicine, 2018 The development of immunotherapies for lymphoma has undergone a revolutionary evolution over the past decades. Since the advent of rituximab as the first successful immunotherapy for B-cell non-Hodgkin lymphoma over two decades ago, a plethora of new ...
Benjamin Heyman, Yiping Yang
doaj +1 more source
Frontiers in Immunology, 2023 BackgroundWe conducted a systematic review and meta-analysis to evaluate outcomes following chimeric antigen receptor T cell (CAR-T) therapy in relapsed/refractory acute myeloid leukemia (RR-AML).MethodsWe performed a literature search on PubMed ...
Moazzam Shahzad +16 more
doaj +1 more source
Epigenetics in the hematologic malignancies
Haematologica, 2014 A wealth of genomic and epigenomic data has identified abnormal regulation of epigenetic processes as a prominent theme in hematologic malignancies. Recurrent somatic alterations in myeloid malignancies of key proteins involved in DNA methylation, post-translational histone modification and chromatin remodeling have highlighted the importance of ...
Chun Yew Fong +2 more
openaire +3 more sources
, 2015 This is an editorial that depicts the importance for developing more quality evidence to guide the survivorship care provision for patients with hematologic malignancies.\ud \ud Treatments for hematologic malignancies are often complex and debilitating ...
Chan, Alexandre, Chan, Raymond Javan
core +1 more source
Blood Neoplasia: Patients with nucleophosmin 1 (NPM1)–mutated acute myeloid leukemia (AML) without a FLT3-internal tandem duplication mutation are considered to have favorable-risk disease that may be cured with intensive chemotherapy (7+3; IC) alone.
Andrew D Zale +14 more
doaj +1 more source
Cytomegalovirus in hematological malignancies [PDF]
Indian Pediatrics, 2013 Cytomegalovirus (CMV) infection frequently causes cytopenia in hematopoietic stem cell transplant setting where there are clear cut recommendations for prophylaxis, screening and pre-emptive treatment of CMV infection [1]. However, evidence of CMV infection in hematological malignancies other than stem cell transplant setting is lacking.
Sameer, Bakhshi, Bivas, Biswas
openaire +2 more sources
Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review [PDF]
, 2020 Objective: Hematologic cancer patients with Coronavirus Disease 2019 (COVID-19) tend to have a more serious disease course than observed in the general population.
이금화 +14 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen +23 more
wiley +1 more source